Review: could Cabergoline cause Chronic Glaucoma?


Chronic glaucoma is reported only by a few people who take Cabergoline. We study 2,418 people who have side effects while taking Cabergoline from FDA and social media. Among them, 3 have Chronic glaucoma. Find out below who they are, when they have Chronic glaucoma and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. (latest outcomes from Cabergoline 2,993 users)

Chronic Glaucoma

Chronic glaucoma (long lasting damage to eye leads vision loss) has been reported by people with osteoporosis, high blood pressure, glaucoma, rheumatoid arthritis, high blood cholesterol (latest reports from 29,282 Chronic glaucoma patients).

On Sep, 26, 2016

2,418 people reported to have side effects when taking Cabergoline.
Among them, 3 people (0.12%) have Chronic Glaucoma

Number of reports submitted per year:

Could Cabergoline cause Chronic glaucoma?

Time on Cabergoline when people have Chronic Glaucoma *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

Gender of people who have Chronic Glaucoma when taking Cabergoline *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Chronic Glaucoma when taking Cabergoline *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

Top conditions involved for these people *:

  • Menopause (1 person, 33.33%)
  • Hyperprolactinaemia (1 person, 33.33%)
  • Acromegaly (1 person, 33.33%)

Top co-used drugs for these people *:

  • Sandostatin Lar (1 person, 33.33%)
  • Putan (1 person, 33.33%)
  • Puran T4 (1 person, 33.33%)
  • Glimepiride (1 person, 33.33%)
  • Femring (1 person, 33.33%)

Top other side effects for these people *:

  • Visual Impairment (1 person, 33.33%)
  • Underweight (1 person, 33.33%)
  • Limb Discomfort (1 person, 33.33%)
  • Gallbladder Disorder (1 person, 33.33%)
  • Drug Ineffective (1 person, 33.33%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Chronic glaucoma when taking Cabergoline?

Browse all side effects of Cabergoline

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Chronic glaucoma

Chronic glaucoma

Could your condition cause Chronic glaucoma

Chronic glaucoma

Related studies

Can you answer these questions?

More questions for: Cabergoline, Chronic glaucoma

You may be interested in these reviews

More reviews for: Cabergoline, Chronic glaucoma

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.